Masimo (MASI) reported $496.3 million in revenue for the quarter ended June 2024, representing a year-overyear increase of 9%. EPS of $0.86 for the same period compares to $0.62 a year ago. The reported revenue represents a surprise of +0.24% over the Zacks Consensus Estimate of $495.09 million. With the consensus EPS estimate being $0.77, the EPS surprise was +11.69%. While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expe ...

Masimo (MASI) came out with quarterly earnings of $0.86 per share, beating the Zacks Consensus Estimate of $0.77 per share. This compares to earnings of $0.62 per share a year ago. These figures are adjusted for nonrecurring items. This quarterly report represents an earnings surprise of 11.69%. A quarter ago, it was expected that this medical technology company would post earnings of $0.71 per share when it actually produced earnings of $0.77, delivering a surprise of 8.45%. Over the last four quarters, th ...

Masimo Stork: More Than Just a Watchful Eye Unlike traditional baby monitors, Masimo Stork goes beyond clear video and sound. It utilizes the same FDAcleared SET® Technology that's been trusted in hospital NICUs for over 25 years. This innovative tech monitors your baby's vitals – second by second! Masimo Stork tracks oxygen saturation, pulse rate, and even skin temperature, providing real-time data on your baby's well-being. ORLANDO, Fla., July 27, 2024 (GLOBE NEWSWIRE) -- As you prepare your little one's ...

Over the past year, this Zacks Rank #2 (Buy) company's shares have lost 7.1% against the industry's 6% growth. The S&P 500 has witnessed 17.6% growth in the said time frame. Image Source: Zacks Investment Research Product Portfolio: We are optimistic about Masimo's healthcare business, which develops, manufactures and markets a variety of non-invasive patient monitoring technologies, hospital automation and connectivity solutions, remote monitoring devices and consumer health products. Strong Q1 Results: Ma ...

Reasons Behind the Litigation The company's shares have lost 6.3% year to date against 4.3% growth of the industry. The S&P 500 has increased 16.9% during the same time frame. The conflict between Masimo and Politan has been a protracted one, centered around Politan's efforts to unseat CEO Joe Kiani. Last year, Politan secured two seats on Masimo's board. In a letter dated Jun 26, COO Bilal Muhsin expressed his intention to resign if Koffey and Politan gain control of the company. Nearly 300 Masimo Healthca ...

The unusually sharp report, a copy of which was viewed by CNBC, said shareholders should vote for activist Politan Capital Management's board nominees, Bill Jellison and Darlene Solomon. ISS' paper comes on the heels of an equally trenchant report from advisory peer Glass Lewis, which issued an identical recommendation last week. Kiani, a close confidant of President Biden and the co-founder of the device company, "has demonstrated that he has no regard for public shareholders," ISS wrote in its report, and ...

Masimo (MASI) recently announced that, on Jul 2, it received a non-binding term sheet confirmation from a third party, which included an acquisition offer for MASI's consumer business. MASI did not provide any details about the third party. More on the Deal Politan Tussle Shares of Masimo have declined 5.1% so far this year against the industry's 3.4% rise and the S&P 500's 18.8% growth. Apart from announcing the term-sheet offer, Masimo announced preliminary results for the second quarter. Consolidated rev ...

Masimo Corporation (MASI) announced preliminary financial results for second-quarter 2024 on Jul 9. Following this release, the company's shares edged up 0.1% in the after-hours trading session. Prelim Q2 in Detail At constant exchange rate (CER), revenues are expected to improve 10.1% year over year. Non-healthcare revenues are expected to be $152 million, down 12.6% and 10.9% year over year on a reported basis and at CER, respectively. Guidance A Brief Q2 Analysis On first-quarter 2024 earnings call in Ma ...

Investors can contact the law firm at no cost to learn more about recovering their losses Investors are encouraged to contact attorney Lesley F. Portnoy, by phone 310-692-8883 or email: lesley@portnoylaw.com, to discuss their legal rights, or click here to join the case via www.portnoylaw.com. The Portnoy Law Firm can provide a complimentary case evaluation and discuss investors' options for pursuing claims to recover their losses. Please visit our website to review more information and submit your transact ...

Existing Masimo W1 Sport owners will soon be able to update their watch firmware and Masimo Health app to begin their sleep-tracking journey with Sleep Halo. Masimo W1 Sport and Sleep Halo are intended for general health and wellness purposes. Masimo W1 is unique among wearables since it continuously measures the wearer's SpO2 and PR and provides a truly informed, robust analysis of how one sleeps. The company has benchmarked Sleep Halo with EEG to confirm its stages of sleep are comparable with sleep analy ...